These compounds do not replace adequate calorie intake, but they can make restricted eating more tolerable
Ozempic pens are not calibrated in generic "units" but rather in specific dose settings in milligrams
nausea common but usually mild Weeks 5-12 (0.5 to 1.0 mg doses): Accelerated weight loss, 0.5-1% of body weight per week Appetite suppression becomes pronounced This is the phase where patients report "forgetting to eat" or feeling full after small portions Cumulative weight loss by week 12: 5-8% of baseline body weight Weeks 13-28 (1.7 to 2.4 mg doses): Continued weight loss at 0.3-0.5% per week Rate of loss slows compared to weeks 5-12, but total loss continues to accumulate Cumulative weight loss by week 28: 10-13% of baseline body weight Weeks 29-68 (2.4 mg maintenance): Weight loss continues but at a slower rate, approximately 0.1-0.2% per week Most patients plateau between weeks 60 and 68 Final cumulative weight loss: 14-17% of baseline body weight in trial populations, 12-15% in real-world populations Beyond 68 weeks: Weight typically stabilizes if treatment continues STEP 5 data shows no further significant loss after week 68, but also no regain if medication continues Discontinuation results in gradual weight regain, with most patients returning to 50-70% of their original weight within 12 months (STEP 4 data) Individual variation is substantial
It's available as a weekly injection and has shown to be beneficial for heart health in people with type 2 diabetes (T2D)
6, 2025, 8:45 AM).e [vii] February Declaratory Order, page 3 (citing Federal Food, Drug, and Cosmetic Act 506E(a))
doi:10.1016/s0165-1838(00)00127-2 43
